Literature DB >> 1912430

The Sydney System: a new classification of gastritis. Introduction.

J J Misiewicz1.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1912430     DOI: 10.1111/j.1440-1746.1991.tb01467.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  30 in total

1.  Pathologists and gastroenterologists.

Authors:  Y Niv
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Upper gastrointestinal endoscopic and histologic findings before and after vertical banded gastroplasty.

Authors:  S T Papavramidis; A J Theocharidis; T G Zaraboukas; B P Christoforidou; I I Kessissoglou; A P Aidonopoulos
Journal:  Surg Endosc       Date:  1996-08       Impact factor: 4.584

3.  Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects.

Authors:  Masaru Nakamura; Ken Haruma; Tomoari Kamada; Mitsuhiro Mihara; Masaharu Yoshihara; Masaaki Sumioka; Toshiyuki Fukuhara; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

4.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Virchows Arch       Date:  2011-12-22       Impact factor: 4.064

5.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

Authors:  M Dinis-Ribeiro; M Areia; A C de Vries; R Marcos-Pinto; M Monteiro-Soares; A O'Connor; C Pereira; P Pimentel-Nunes; R Correia; A Ensari; J M Dumonceau; J C Machado; G Macedo; P Malfertheiner; T Matysiak-Budnik; F Megraud; K Miki; C O'Morain; R M Peek; T Ponchon; A Ristimaki; B Rembacken; F Carneiro; E J Kuipers
Journal:  Endoscopy       Date:  2011-12-23       Impact factor: 10.093

6.  ABH and Lewis antigen distributions in blood, saliva and gastric mucosa and H pylori infection in gastric ulcer patients.

Authors:  Luisa Caricio Martins; Tereza Cristina de Oliveira Corvelo; Henrique Takeshi Oti; Rosane do Socorro Pompeu Loiola; Delia Cristina Figueira Aguiar; Katarine Antonia dos Santos Barile; Renata Kelly Costa do Amaral; Hivana Patricia Melo Barbosa; Amanda Alves Fecury; Juciclayton Tavares de Souza
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

7.  Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study.

Authors:  S G R G Barton; D S Rampton; V R Winrow; P Domizio; R M Feakins
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

8.  Isolation and preliminary evaluation of a low-molecular-mass antigen preparation for improved detection of Helicobacter pylori immunoglobulin G antibodies.

Authors:  L P Andersen; F Espersen; A Souckova; M Sedlackova; A Soucek
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

9.  Antigastric autoantibodies in Helicobacter pylori gastritis: prevalence, in-situ binding sites and clues for clinical relevance.

Authors:  G Faller; H Steininger; M Eck; J Hensen; E G Hann; T Kirchner
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

Review 10.  Pathophysiological effects of long-term acid suppression in man.

Authors:  R F McCloy; R Arnold; K D Bardhan; D Cattan; E Klinkenberg-Knol; P N Maton; R H Riddell; P Sipponen; A Walan
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.